FDA Guidance Aims to Reduce Adhesion Failures of Generic Patches

FDA aims to help manufacturers improve the adhesive qualities of transdermal patches in a new guidance. Agency official says that poor adhesion is a major quality problem with these patches and has been the source of numerous recalls.